Catalog No.
MHC13302
Species reactivity
Human
Host species
Mouse
Isotype
IgG
Clonality
Monoclonal
Immunogen
Human Calprotectin (S100A8/S100A9) Protein.
Target
Protein S100-A8, Calgranulin-A, Calprotectin L1L subunit, Cystic fibrosis antigen, CFAG, Leukocyte L1 complex light chain, Migration inhibitory factor-related protein 8, MRP-8, p8, S100 calcium-binding protein A8, Urinary stone protein band A, S100A8, CAGA, CFAG, MRP8, Protein S100-A9, Calgranulin-B, Calprotectin L1H subunit, Leukocyte L1 complex heavy chain, Migration inhibitory factor-related protein 14, MRP-14, p14, S100 calcium-binding protein A9, S100A9, CAGB, CFAG, MRP14
Concentration
1mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
P05109, P06702
Applications
GICA, IFA
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Clone ID
1A317
Synergistic inhibition of CitH3 and S100A8/A9: A novel therapeutic strategy for mitigating sepsis-induced inflammation and lung injury., PMID:40390290
Cohort profile: the Swedish Inception Cohort in inflammatory bowel disease (SIC-IBD)., PMID:40328654
Long-Term Outcomes Following Withdrawal of Anti-Tumour Necrosis Factor Treatment in Inflammatory Bowel Disease Patients in Remission: The Exit Long-Term Study of GETECCU., PMID:40317957
Granulocyte and Monocyte Adsorptive Apheresis Maintenance Therapy Restored the Loss of Response to Anti-TNF-Alpha Agents in the Patients With UC: A Case Report., PMID:40313140
Neutrophil Z Is a Novel Marker to Differentiate Disease Flares From Bacterial Infections in Febrile SLE Patients., PMID:40302194
Fatigue in Inflammatory Bowel Disease: No Effect of Serum Concentrations of Infliximab, Adalimumab or Anti-Drug Antibodies During Maintenance Therapy., PMID:40289444
Identification of S100A9 as a target for diagnosis and treatment of Crohn's Disease after Vedolizumab treatment failure., PMID:40280281
[The effects of S100A9 gene knockout on lupus-like phenotype in mice]., PMID:40260564
1000-plex antibody array proteomic screen uncovers PGRPS, Haptoglobin, Serpin A4 and Fibrinogen as potential stool biomarkers of pediatric inflammatory bowel disease., PMID:40252987
Anti-integrin αvβ6 IgG antibody as a diagnostic and prognostic marker in ulcerative colitis: A cross-sectional and longitudinal study defining a specific disease phenotype., PMID:40251889
Efficacy and safety of intravenous vedolizumab treatment in Chinese patients with moderate-to-severe Crohn's disease., PMID:40228712
Development of novel neutralizing single-chain fragment variable antibodies against S100A8., PMID:40221535
Limitations of Faecal Calprotectin in Detecting Histological Changes and Persistent Villous Atrophy in Patients With Coeliac Disease on a Gluten-Free Diet., PMID:40170592
Helminth driven gut inflammation and microbial translocation associate with altered vaccine responses in rural Uganda., PMID:40140378
Enterocolitis associated with glofitamab-First report and clinicopathological findings in three cases., PMID:40108860
Extracellular vesicle-bound S100A8/A9 is differentially expressed in septic shock and prompts acute lung injury., PMID:40102943
Novel Methods for the Analysis of Serum NET Remnants: Evaluation in Patients with Severe COVID-19., PMID:40076841
Neutrophil-derived exosomal S100A8 aggravates lung injury in sepsis by inducing pyroptosis., PMID:40056630
Early CTLA4 increase in CD45+ blood cells: an emerging biomarker of atezolizumab-bevacizumab resistance and worse survival in advanced hepatocarcinoma., PMID:40048814
Targeting S100A8/A9-NCF1 axis in tumor microenvironment to prevent tumor metastasis by self-assembled peptide nanofibers., PMID:40040282
Viral and Immune Factors Associated With COVID-19 Outcome in the C3PO Trial of Convalescent Plasma., PMID:40037339
E-twenty-six-specific sequence variant 5 (ETV5) facilitates hepatocellular carcinoma progression and metastasis through enhancing polymorphonuclear myeloid-derived suppressor cell (PMN-MDSC)-mediated immunosuppression., PMID:40015948
The role of gluten and wheat in irritable bowel syndrome and noncoeliac gluten or wheat sensitivity., PMID:39998947
Ustekinumab for ulcerative colitis: a nationwide real-life observational cohort study., PMID:39970041
Switching intravenous to subcutaneous infliximab was safe and successful during 1-year follow up in Ulcerative Colitis and Crohn patients - a Belgian single center experience., PMID:39961295
Therapeutic drug monitoring and immunogenetic factors associated with the use of adalimumab in Crohn's disease patients., PMID:39959979
Outcomes of oral vancomycin therapy in children with atypical ulcerative colitis with or without confirmed primary sclerosing cholangitis: a real-world observational study., PMID:39938966
A child with Chronic Nonbacterial Osteomyelitis and celiac disease: accidental association or two different aspects of the same condition?, PMID:39885545
Maintenance-phase serum anti-TNF levels are not associated with mucosal healing in pediatric Crohn's disease., PMID:39871722
Baseline Drug Clearance Predicts Outcomes in Children With Inflammatory Bowel Disease Treated With Vedolizumab: Results From the VedoKids Prospective Multicentre Study., PMID:39812549
RNF128 deficiency in macrophages promotes colonic inflammation by suppressing the autophagic degradation of S100A8., PMID:39809743
Fecal Calprotectin Determination in a Cohort of Children with Cow's Milk Allergy., PMID:39796628
Withdrawal of antitumour necrosis factor in inflammatory bowel disease patients in remission: a randomised placebo-controlled clinical trial of GETECCU., PMID:39794921
Deletion of metal transporter Zip14 reduces major histocompatibility complex II expression in murine small intestinal epithelial cells., PMID:39793074
[Inflammatory bowel diseases in children and adolescents : An overview with particular attention to genetic testing]., PMID:39774688
Vedolizumab Clearance as a Surrogate Marker for Remission in Inflammatory Bowel Disease Patients: Insights from Real-World Pharmacokinetics., PMID:39771608
Synovial Fluid Markers and Extracellular Vesicles in Rheumatoid Arthritis., PMID:39768826
Fecal Nervonic Acid as a Biomarker for Diagnosing and Monitoring Inflammatory Bowel Disease., PMID:39767671
A pan-immune panorama of bacterial pneumonia revealed by a large-scale single-cell transcriptome atlas., PMID:39757231
Olfactory cleft brushing: A minimally invasive tool for biomarker analysis in rhinology., PMID:39721256
Real-world experience and long-term outcomes of a mandatory non-medical switch of adalimumab originator to biosimilars in inflammatory bowel disease., PMID:39679312
Gut microbiota diversity repeatedly diminishes over time following maintenance infliximab infusions in paediatric IBD patients., PMID:39666667
Rapid prediction of acute thrombosis via nanoengineered immunosensors with unsupervised clustering for multiple circulating biomarkers., PMID:39661669
Ulcerative Colitis Severity Classification and Localized Extent (UC-SCALE): An Artificial Intelligence Scoring System for a Spatial Assessment of Disease Severity in Ulcerative Colitis., PMID:39657580
Serum Neutrophil Biomarkers to Predict Crohn's Disease Progression and Infliximab Treatment Outcomes., PMID:39648597
The need for Cre-loci controls in conditional mouse experiments: Mrp8-cre transgene predisposes mice to antibody-induced arthritis., PMID:39632992
Impact of ustekinumab exposure on clinical outcomes during induction in inflammatory bowel disease., PMID:39629805
Associations of poor water, sanitation, and hygiene and parasite burden with markers of environmental enteric dysfunction in preschool-age children infected with Schistosoma mansoni in Uganda., PMID:39618064
Limited validity of Mayo endoscopic subscore in ulcerative colitis with concomitant primary sclerosing cholangitis., PMID:39600557
Changes in Immunoglobulins G and A in the Saliva and Serum of Horses with Equine Gastric Ulcer Syndrome (EGUS) and Their Relationship with Other Immune and Redox Status Biomarkers., PMID:39596846
For research use only. Not for human or drug use.
